Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Thursday, 4 January 2018

Shire to present at the 36th Annual J.P. Morgan Healthcare Conference

Shire plc    

Shire to present at the 36th Annual J.P. Morgan Healthcare Conference


Shire to present at the 36th Annual J.P. Morgan Healthcare Conference


Cambridge, MA - January 4, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Flemming Ornskov, M.D., M.P.H., Chief Executive Officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in in San Francisco, California on Monday, January 8th, 2018, at 10:30 AM Pacific Standard Time (18:30 GMT).


A live audio webcast of the presentation and the questions & answers session will be available on Shire's Investor website at http://investors.shire.com/presentations-and-reports. Subsequently, a replay of the webcast will be available on this same website for approximately 90 days.


For further information please contact:


Investor Relations



Christoph Brackmann


+41 79 543 3259

Sun Kim


+1 617 588 8175

Robert Coates


+44 203 549 0874




Lisa Adler


+1 617 588 8607

Katie Joyce


+1 781 482 2779




About Shire


Shire is the global leader in serving patients with rare diseases. We strive to develop best-in-class therapies across a core of rare disease areas including hematology, immunology, genetic diseases, neuroscience, and internal medicine with growing therapeutic areas in ophthalmics and oncology. Our diversified capabilities enable us to reach patients in more than 100 countries who are struggling to live their lives to the fullest.


We feel a strong sense of urgency to address unmet medical needs and work tirelessly to improve people's lives with medicines that have a meaningful impact on patients and all who support them on their journey.



This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of Nasdaq Corporate Solutions clients. Source: Shire plc, 1 Kingdom Street Paddington, London W2 6BD, United Kingdom
If you would like to unsubscribe and stop receiving these e-mails click here.